Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 6, 2013

Elite, GSK, Novartis, Pacira, Rhizen, Shire, Theravance

Phase I
Rhizen begins FIH trial for blood diseases . . . read more

Phase II
Elite begins bioequivalence study of abuse-deterrent painkiller . . . read more

TGT Starts CLL, MCL Trial . . . read more

Phase III
GSK, Theravance post good asthma results . . . read more

Novartis myleoma treatment extends PFS . . . read more

Shire eye drug misses clinical endpoint . . . read more

Filings
Pacira files PAS for Exparel . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters